Clostridioides Difficile
4 clinical trials · Condition
◉ Watch Clostridioides Difficile
| Record | Firm | Date |
|---|---|---|
| Bezlotoxumab Versus FMT for Multiple Recurrent CDI (NCT05077085) | Leiden University Medical Center | 2022-01-01 |
| Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection (NCT03788434) | Vedanta Biosciences, Inc. | 2019-02-08 |
Track Clostridioides Difficile automatically
Every clearance here is in the API, with alerts when new ones post.